4//SEC Filing
Rowland Charles A Jr 4
Accession 0001193125-26-003110
CIK 0001607678other
Filed
Jan 4, 7:00 PM ET
Accepted
Jan 5, 8:25 PM ET
Size
6.7 KB
Accession
0001193125-26-003110
Insider Transaction Report
Form 4
Rowland Charles A Jr
Director
Transactions
- Award
Common Stock, par value $0.00001 per share
2026-01-02+3,150→ 33,150 total - Award
Stock Option (Right to Buy)
2026-01-02+20,400→ 20,400 totalExercise: $35.42From: 2027-01-02Exp: 2036-01-02→ Common Stock (20,400 underlying)
Footnotes (1)
- [F1]Represents a restricted stock unit award ("RSU") of common stock under the Issuer's 2024 Equity Incentive Plan. All shares subject to the RSU shall vest on the one year anniversary of the grant date of the award.
Documents
Issuer
Viking Therapeutics, Inc.
CIK 0001607678
Entity typeother
Related Parties
1- filerCIK 0001383292
Filing Metadata
- Form type
- 4
- Filed
- Jan 4, 7:00 PM ET
- Accepted
- Jan 5, 8:25 PM ET
- Size
- 6.7 KB